The study found that patients in group B, who presented with AIDS later, had significantly better survival rates compared to those in group A, who presented early. This suggests that early medical intervention in HIV infection delays the onset of AIDS but may decrease subsequent survival when AIDS develops. The findings are consistent with studies such as the Concorde trial, which showed that early zidovudine treatment delayed AIDS development without improving overall survival. The study highlights the public health challenge posed by patients presenting with AIDS coincidental to their first positive HIV test and contributes to the debate on the effects of medical intervention on survival after AIDS-defining illness.The study found that patients in group B, who presented with AIDS later, had significantly better survival rates compared to those in group A, who presented early. This suggests that early medical intervention in HIV infection delays the onset of AIDS but may decrease subsequent survival when AIDS develops. The findings are consistent with studies such as the Concorde trial, which showed that early zidovudine treatment delayed AIDS development without improving overall survival. The study highlights the public health challenge posed by patients presenting with AIDS coincidental to their first positive HIV test and contributes to the debate on the effects of medical intervention on survival after AIDS-defining illness.